U.S. Pharma Stock News

NasdaqGS:CDXS
NasdaqGS:CDXSLife Sciences

Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement

Why Codexis Is Back on Investors’ Radar Codexis (CDXS) has drawn fresh attention after reporting fourth quarter 2025 results, with revenue of US$38.92 million and net income of US$9.6 million, alongside new full year 2026 revenue guidance. The company also recently signed an agreement to manufacture 50 grams of siRNA for a pharmaceutical partner using its ECO Synthesis platform, adding a commercial data point around its RNA manufacturing capabilities. See our latest analysis for Codexis. At a...
NYSE:FUN
NYSE:FUNHospitality

Does Travis Kelce’s Brand Deal Reveal a New Marketing Playbook for Six Flags (FUN)?

Earlier this week, Six Flags Entertainment announced a partnership naming three-time Super Bowl champion Travis Kelce as a brand ambassador for its 2026 season, giving the company rights to use his name, image, and digital content across social media, broadcast, streaming, and in-park marketing. This collaboration underscores Six Flags’ push to refresh its brand and deepen fan engagement by linking its parks to a high-profile NFL personality with broad mainstream appeal. We’ll now examine...
NYSE:WMB
NYSE:WMBOil and Gas

Should Williams’ Data Center Push and Higher Dividend Payout Reshape How WMB Investors View the Stock?

In recent days, Williams Companies outlined plans to expand its natural gas infrastructure and explore upstream asset purchases to supply power-hungry data centers and AI-related facilities, while also issuing 2026 EBITDA guidance, growth capital plans, and announcing a 5% increase in its annual dividend to US$2.10 per share. At the same time, Williams has drawn attention from major ETFs, hosted executives at high-profile industry forums, and seen insider share sales and updated analyst...
NYSE:IBP
NYSE:IBPConsumer Durables

Can Installed Building Products’ (IBP) Heavy Commercial Strength Outweigh Insider Selling and Analyst Caution?

Installed Building Products recently reported strong earnings, with growth in its heavy commercial segment helping offset weaker installation-related revenues amid ongoing single-family housing softness and uncertainty in private non-residential development. At the same time, analysts have kept cautious ratings and insider selling has continued, underscoring a tension between operational resilience and perceived sector and cost risks. We’ll now examine how this heavy commercial-driven...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Does MGE Energy’s (MGEE) Insider Buying and Dividend Streak Reveal Its True Capital Return Priorities?

MGE Energy recently reported stronger-than-expected earnings with solid revenue growth, brought new clean energy assets online, extended its multi-decade dividend-raise streak, and saw director James G. Berbee increase his shareholding through an insider purchase. Together with an at-the-market equity program and fresh analyst commentary on renewables and data center-related demand, these moves point to a company emphasizing financial flexibility, long-term capital returns, and board-level...
NYSE:MAS
NYSE:MASBuilding

Masco’s Softer Quarter and Strategy Reassessments Might Change The Case For Investing In Masco (MAS)

In the most recent quarter, Masco reported revenue of US$1.79 billion, a 1.9% year-on-year decline that missed analyst expectations by 1.5%, underscoring a softer period amid cyclical pressures in home construction materials. Behind the headline miss, Masco’s lagging organic revenue growth, flat earnings per share versus peers, and recent need to reassess product, pricing, or go-to-market strategy raise questions about its competitive position even as dividend growth remains a key...
NYSE:MLM
NYSE:MLMBasic Materials

A Look At Martin Marietta Materials (MLM) Valuation After Recent Share Price Pullback

Why Martin Marietta Materials is on investors’ radar today Martin Marietta Materials (MLM) has drawn fresh attention after recent trading left the shares about 12% lower over the past month and roughly 7% lower over the past 3 months. See our latest analysis for Martin Marietta Materials. While the recent 30 day and 90 day share price returns of 11.77% and 7.08% declines suggest fading short term momentum, the 1 year and 3 year total shareholder returns of 22.92% and 85.25% highlight a...
NYSE:ALK
NYSE:ALKAirlines

Is Alaska Air Group (ALK) Pricing Make Sense After Recent Share Price Slide

If you are wondering whether Alaska Air Group is a bargain or a value trap at around US$38 per share, you are not alone, and the answer depends on how you look at its valuation. The stock has seen sharp moves recently, with a 10.2% decline over the last 7 days, a 33.9% decline over 30 days, and a 26.2% decline year to date, on top of a 29.6% decline over the past year and 46.3% over five years. These price swings have kept Alaska Air Group on many investors' watchlists, as they reassess what...
NYSE:WHD
NYSE:WHDEnergy Services

Cactus Insider Selling Raises Questions On Confidence And Shareholder Alignment

Cactus (NYSE:WHD) executives Joel Bender and Scott Bender have disclosed significant insider stock sales in March 2026. The President and the Chairman/CEO together sold more than 200,000 shares, according to recent SEC filings. There have been no insider purchases reported at Cactus over the past year, highlighting a one sided pattern of insider activity. Cactus, which trades on the NYSE under the ticker WHD, last closed at $46.36. The stock is down 7.3% over the past week and 19.1% over...
NYSE:QSR
NYSE:QSRHospitality

Is Restaurant Brands International (QSR) Pricing Reflect Its Cash Flow Forecasts And Recent Share Performance

If you are wondering whether Restaurant Brands International at around US$72.65 is offering fair value or a potential mismatch between price and business quality, you are not alone. The stock shows a 1.8% decline over the last 7 days, a 2.8% gain over 30 days, and returns of 7.1% year to date, 14.1% over 1 year, 31.9% over 3 years, and 33.3% over 5 years, which may prompt questions about how much of the story is already reflected in the share price. Recent coverage has focused on Restaurant...
NasdaqCM:IMPP
NasdaqCM:IMPPOil and Gas

Assessing Imperial Petroleum (IMPP) Valuation After Strong Q4 2025 Earnings And Share Price Momentum

Why Imperial Petroleum is on investors’ radar right now Imperial Petroleum (IMPP) is getting fresh attention after reporting Q4 2025 results that showed higher sales and net income versus the same quarter a year earlier, alongside steady preferred dividend activity. See our latest analysis for Imperial Petroleum. The recent Q4 2025 report and ongoing preferred dividend payments have arrived alongside a 30 day share price return of 23.20% and a 1 year total shareholder return of 87.80%. This...
NYSE:PPL
NYSE:PPLElectric Utilities

PPL’s First Base Rate Hike Since 2016 Might Change The Case For Investing In PPL (PPL)

PPL Electric Utilities recently filed a joint petition for a non-unanimous settlement with the Pennsylvania Public Utility Commission seeking approval for a base distribution rate increase, which would support system reliability and resilience and, if approved, take effect on July 1, 2026, its first such increase since 2016. This proposed rate adjustment highlights how PPL is trying to balance sizable grid investment needs with customer affordability and regulatory oversight, a combination...
NYSE:LPX
NYSE:LPXForestry

How Investors Are Reacting To Louisiana-Pacific (LPX) Launching Its BurnGuard Fire-Retardant OSB Panel

Earlier this month, LP Building Solutions launched LP BurnGuard Fire-Retardant-Treated Oriented Strand Board, the first OSB panel certified to meet IBC and IRC definitions for fire-retardant-treated wood structural panels, integrating fire protection directly into the strands during manufacturing. This patent-pending, in-house-produced panel broadens LP’s fire-rated portfolio and could make it easier for multifamily builders to meet evolving code requirements without altering existing...
NYSE:IMAX
NYSE:IMAXEntertainment

IMAX Leans On Studio Ghibli Events As Shares Trade Below Targets

IMAX (NYSE:IMAX) and GKIDS are expanding their partnership to bring newly remastered Studio Ghibli titles Whisper of the Heart and The Secret World of Arrietty to IMAX theatres across North America this spring. The releases continue IMAX’s work with GKIDS and Studio Ghibli following prior remastered Ghibli runs in the IMAX format. For investors tracking IMAX at a share price of $38.1, this move fits into a broader push to lean on distinctive content that sets the format apart from standard...
NYSE:RSI
NYSE:RSIHospitality

A Look At Rush Street Interactive (RSI) Valuation After Strong Q4 Results And Upbeat 2026 Guidance

Recent coverage of Rush Street Interactive (RSI) has focused on fourth quarter results that exceeded expectations, record revenue and EBITDA, and guidance for 2026 that came in above analyst consensus views. See our latest analysis for Rush Street Interactive. The recent analyst enthusiasm and strong fourth quarter update sit alongside a 30 day share price return of 18.42% and a one year total shareholder return of 89.25%, while the three year total shareholder return is very large at over...
NYSE:IRM
NYSE:IRMSpecialized REITs

Is Iron Mountain (IRM) Still Attractive After 28% One Year Share Price Gain

If you have been wondering whether Iron Mountain's share price really matches what the business is worth, this article will walk through how its current valuation stacks up. The stock last closed at US$106.84, with returns of 1.6% over 7 days, 6.6% over 30 days, 28.4% year to date and 27.8% over 1 year. That performance may have caught your eye if you track steady compounders. Recent coverage has focused on Iron Mountain's role in data center and storage services, as investors weigh how its...
NYSE:ASB
NYSE:ASBBanks

Assessing Associated Banc-Corp (ASB) Valuation After Recent Share Price Pullback

Why Associated Banc-Corp Is On Investors’ Radar Today Associated Banc-Corp (ASB) has drawn fresh attention as investors reassess recent share performance, with the stock showing a 13.47% decline over the past month and a 9.67% decline over the past 3 months. See our latest analysis for Associated Banc-Corp. While the recent 30 day share price return of 13.47% decline and 90 day share price return of 9.67% decline suggest fading momentum, the 1 year total shareholder return of 15.66% points to...
NYSE:CVX
NYSE:CVXOil and Gas

Is Chevron (CVX) Pricing Reflecting Hess Deal Prospects After Strong Multi Year Share Gains

If you are wondering whether Chevron’s recent share price puts it at a premium or a bargain, this article walks through what the current valuation really suggests. Chevron shares last closed at US$196.82, with returns of 3.6% over the past 7 days, 5.9% over 30 days, 26.2% year to date, 31.0% over 1 year, 46.7% over 3 years and 134.5% over 5 years. These figures may influence how investors think about upside and risk today. Recent headlines around Chevron have focused on its position as a...
NYSE:LRN
NYSE:LRNConsumer Services

Is Stride (LRN) Pricing Reflect Its Long Term Value After Recent Share Price Swings

If you are trying to figure out whether Stride's current share price reflects its real value, you are in the right place to break that question down in a practical way. Stride's shares last closed at US$84.36, with returns of a 2.8% decline over 7 days, a 1.8% decline over 30 days, a 30.6% gain year to date, a 30.5% decline over the past year, a 118.2% gain over 3 years and a 199.1% gain over 5 years. These mixed returns sit against a backdrop of ongoing interest in online and blended...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

What PTC Therapeutics (PTCT)'s FDA Leadership Shift Means For Its Gene and RNA Pipeline Narrative

Earlier this week, PTC Therapeutics was lifted by a broader biotech upswing after the departure of an FDA official viewed as a hurdle to accelerated approvals in cell and gene therapies, prompting investors to reassess regulatory risk across the sector. The shift in FDA leadership has reduced perceived barriers for PTC’s gene and RNA-based pipeline, sharpening focus on how regulatory attitudes might influence its rare disease portfolio. We’ll now examine how this change in perceived FDA...
NYSE:CNC
NYSE:CNCHealthcare

Is Centene (CNC) Rebalancing for Stability or Signaling Strain in Its Core Health Plan Model?

Centene Corporation recently presented at Barclays’ 28th Annual Global Healthcare Conference in Miami, where management reaffirmed 2026 earnings guidance and announced a partial redemption of US$1.00 billion of 4.25% notes due 2027. At the same time, the company reported a sharp drop in Affordable Care Act marketplace enrollment and rising specialty pharmacy utilization, highlighting pressure points within its core government-focused health plan portfolio. We’ll now explore how the steep ACA...
NYSE:SYY
NYSE:SYYConsumer Retailing

What Sysco (SYY)'s CFO Exit and Reaffirmed 2026 Guidance Means For Shareholders

In late February 2026, Sysco Corporation’s Chief Financial Officer Kenny Cheung resigned to join a Fortune 10 company outside foodservice, with longtime internal finance leader Brandon Sewell appointed interim CFO from March 6 while Cheung stays on as an advisor until mid-April to support continuity. By reaffirming its fiscal 2026 earnings guidance alongside the CFO transition, Sysco signaled management’s confidence in its existing financial plans and execution framework despite the...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

Assessing MillerKnoll (MLKN) Valuation After Mixed Recent Share Performance And A 40.8% Undervaluation View

MillerKnoll stock snapshot MillerKnoll (MLKN) is back on investor radars after recent share price moves, with the stock now around $18.96 and mixed returns across the past week, month, and past 3 months. See our latest analysis for MillerKnoll. Recent moves in MillerKnoll’s share price tell a mixed story, with a 30 day share price return of a 16.73% decline, contrasting with a 90 day share price return of a 13.81% gain and a 1 year total shareholder return of 3.23%. This suggests momentum has...
NYSE:SE
NYSE:SEMultiline Retail

Why Sea (SE) Is Down 6.5% After Mixed Q4 2025 Results Test Its Investment Story

In early March 2026, Sea Limited reported its fourth-quarter and full-year 2025 results, with revenue rising to US$6,851.87 million for the quarter and US$22.94 billion for the year, while net income increased to US$397.10 million and US$1.58 billion respectively, alongside completing a US$14.50 million share buyback of 116,200 shares announced in November 2025. The results highlight strong top-line and earnings growth across Shopee, SeaMoney, and Garena, but also reveal that heavier...